An innovative model for fighting HIV/AIDS in Africa is being piloted in Botswana through a public-private partnership involving the Government of Botswana, the Bill & Melinda Gates Foundation and Merck & Co., Inc. The partnership is intended to help Botswana achieve an "AIDS-Free Generation by 2016" by expanding prevention, supporting treatment, increasing counseling and testing, and empowering communities.

The event featured: Dr. Themba Moeti, Managing Director of African Comprehensive HIV/AIDS Partnerships. Discussants included:

• David Greeley, Senior Director, HIV/AIDS Programs, Merck & Co., Inc. and Board Member, African Comprehensive HIV/AIDS Partnerships
• April Harding, CGD visiting fellow, Center for Global Development
• Mead Over, CGD senior fellow

The event was moderated by Nandini Oomman, CGD senior program associate and project director for the HIV/AIDS Monitor Initiative.

Download Dr. Themba Moeti's presentation (PDF, 7.8MB)

Download Mead Over's presentation (PDF, 3.1MB)

Read Mead Over's chapter, "Impact of the HIV/AIDS Epidemic on the Health Sectors of Developing Countries" (from Markus Haacker's The Macroeconomics of HIV/AIDS[IMF, 2004])